Biotech Values

[bladerunner1717]

David,

I'm not sure that I understand your reasoning. Why didn't you want them to focus on breast cancer? Would you have preferred that they focus on lung cancer? Why was the subgroup of patients who did not present with brain mets at time of diagnosis a "FAR more scientifically sensible subgroup of patients?" Subgroup of what patients? Does this mean you don't like the construction of the current Phase III? (Because it includes breast cancer patients with brain mets.)

The breast cancer lobby was not entirely in favor of approvable. NBCC was opposed. I believe their opposition had an egotistic/political purpose: They felt they were not adequately involved in the trial. They are far more involved, as I understand it, in the current trial.

I'm not disagreeing with you, but I can't seem to follow your logic here. Maybe you can explicate better, so that my simple mind can grasp what you're saying.

Do you like ALTH now?


Bladerunner